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Abstract 
Biomaterials made of biodegradable poly(α-hydroxyesters) like poly(lactide-co-glycolide) 
(PLGA) are known to decrease the pH in the vicinity of the implants. Bioactive glass (BG) is 
being investigated as a counteracting agent buffering the acidic degradation products. 
However, in dentistry the question arises whether an antibacterial effect is rather obtained 
from pure PLGA or from BG/PLGA composites, as BG has been proved antimicrobial. In the 
present study the antimicrobial properties of electrospun PLGA and BG45S5/PLGA fibres 
were investigated using human oral bacteria (specified with mass spectrometry) incubated for 
up to 24 h. BG45S5 nanoparticles were prepared by flame spray synthesis. The change in 
colony-forming units (CFU) of the bacteria was put into correlation with the pH of the 
medium during incubation. Morphology and structure of the scaffolds as well as the 
appearance of the bacteria were followed by microscopy. Additionally, we studied if the 
presence of BG45S5 had an influence on the degradation speed of the polymer. Finally, it 
turned out that the pH increase induced by BG45S5 presence in the scaffold did not last long 
enough to show a reduction in CFU. On the contrary, pure PLGA demonstrated antibacterial 
properties that should be taken into consideration when designing biomaterials for dental 
applications.  
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1. Introduction 
Polymers and ceramics are two classes of materials that can be combined into porous, 
biodegradable and bioactive hybrids [1]. New biomaterials are designed to replace certain 
functions in the body and, thus, a vast field for biomedical composites in tissue engineering 
opens. Among synthetic polymers [2-4], poly(α-hydroxyesters) are most often used and are 
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very well investigated [5-7]. The copolymer poly(lactide-co-glycolide) (PLGA) approved by 
the Food and Drug Administration (FDA) is very promising as its properties may be tailored 
according to the ratio of the two constituents [5, 8]. Yet, PLGA lacks certain features, e.g. pH 
buffer effect, osteoinductivity, osteoconductivity, bioactivity, etc. that may be overcome by 
adding ceramics, to obtain a desired composite. 
Ever since its introduction by Hench et al. in 1971 [9], bioactive glass (BG) offers great 
potential for biomedical applications. Next to its bone bonding feature, BG is also found to be 
antibacterial [10-12]. A most recent review by Jones highlights the commercial products using 
BG [11]. Boccaccini et al. summarised the beneficial properties of nanoscale BG, namely 
enhanced osteoconductivity compared to micron-sized material and the emerging possibilities 
for nanocomposites [13]. 
BG with various compositions (45S5 [14-20] or other [21-25]) have been mixed with PLGA 
to render the latter osteoconductive and in order to overcome the issue of inflammation 
responses caused by the acidic degradation by-products of PLGA. However, even if 
counterproductive in the orthopaedic field, one might think of the pH drop induced by PLGA 
as an antimicrobial tool useful in dentistry, especially, as this biomaterial design would 
function according to the same principle as the barrier put up by the stomach, which is known 
to be an effective obstacle for harmful bacteria [26].  
To our best knowledge, among the different techniques used to produce BG-polymer 
composites [1, 11, 13], up to now, electrospinning has only been applied with sodium-free 
bioactive glass [27-34]. Usually, the electrospinning solution was obtained by mixing a sol-
gel precursor of BG with a polymer solution. Bretcanu et al. and Yunos et al. electrospun 
their polymer onto BG45S5 pellets [35, 36], while in this study the BG45S5/PLGA composite 
was prepared by electrospinning a dispersion of the inorganic phase in the polymer solution. 
BG45S5 nanoparticles necessary to produce a stable dispersion for electrospinning were 
produced by flame spray synthesis. 
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The question remains whether electrospun PLGA or BG45S5/PLGA is a more effective 
disinfectant. This shall be clarified by studying the viability of human oral bacteria cultured 
on the two materials. The hypothesis of this study was that both scaffolds influence the 
viability of bacteria by a pH shift. 
 
2. Materials and methods 
 
2.1 Spherical, dispersible BG45S5 nanoparticles 
Amorphous BG nanoparticles (BG45S5, 45.0 wt% SiO2, 24.5 wt% Na2O, 24.5 wt% CaO and 
6.0 wt% P2O5) were prepared by flame spray synthesis according to a previously described 
procedure [37, 38]. Briefly, precursors of hexamethyldisiloxane (Acros Organics, Geel, 
Belgium, 98%), calcium-2-ethylhexanoic acid (AppliChem, Darmstadt, Germany, Ph. Eur. 
and Sigma-Aldrich, St Louis, USA, 99%), sodium-2-ethylhexanoic acid (Riedel-de Haën, 
Seelze, Germany, Ph. Eur. and Sigma-Aldrich, St Louis, USA, 99%) and tributyl phosphate 
(Sigma-Aldrich, St Louis, USA, 98%) were mixed accordingly. The mixture was diluted with 
tetrahydrofuran (THF, Fisher Scientific, Waltham, USA, unstabilised) at a volume ratio of 
2:1, dispersed with oxygen (5 L min-1) and fed (5 mL min-1) through a capillary (diameter 0.4 
mm) into a methane/oxygen flame. As formed BG nanoparticles (production rate: 25 g h-1) 
were collected on metal filters and sieved (300 µm mesh) subsequently. 
 
2.2 Nanocomposite scaffolds 
PLGA (copolymer ratio of 85/15, Boehringer Ingelheim, Ingelheim am Rhein, Germany, 
Resomer Sample MD Type RG) was dissolved in chloroform (Sigma-Aldrich, St Louis, USA, 
Ph. Eur.). The electrospinning solution contained 6.5 wt% PLGA (referred to the total 
solution weight) and 5.0 wt% Tween20 (referred to the PLGA weight, Polysorbate20, Fluka 
Analytical, St Louis, USA, Ph. Eur.). During electrospinning the polymer solution was fed 
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with 4 mL h-1 through a capillary (inner diameter = 1.0 mm) using the dry ice experimental 
set-up described elsewhere [39]. A high voltage of 20 kV was applied to the needle tip, which 
was kept in a chloroform/air stream [40]. The distance between the needle tip and the 
cylindrical collector (diameter = 8 cm, covered with aluminium foil) was kept at 20 cm. The 
cylindrical collector was filled completely with dry ice (~500 g). This allowed dry ice 
electrospinning for 75 consecutive minutes. The scaffolds were immediately stored under 
vacuum at room temperature (RT).  
Electrospun scaffolds containing 30 wt% of BG45S5 nanoparticles were produced by first 
dispersing the corresponding amount of BG45S5 nanoparticles in a solution of THF and 
dimethylformamide (DMF, Sigma-Aldrich, St Louis, USA, Ph. Eur) by ultrasonication 
(Hielscher, Teltow, Germany, UP400S) for 5 min applying pulsed intervals (volume ratio 
THF:DMF = 3:1). Subsequently, PLGA was dissolved under stirring for 2 h at a concentration 
of 0.083 g mL-1 with 3 wt% Tween20 (referred to the PLGA weight). Dry ice electrospinning 
was carried out at 20 kV with a distance of 15 cm and the dispersion being fed at 3 mL h-1. No 
solvent/air stream was applied at the nozzle. 
 
2.3 BG45S5 nanoparticles and scaffold characterisation 
Transmission electron microscopy (TEM, FEI, Eindhoven, The Netherlands, Tecnai F30 ST) 
and Brunauer-Emmett-Teller (BET) surface area (Micromeritics, Norcross, USA, Tristar 
3000) were used to characterise the BG45S5 nanoparticles. X-ray diffraction (XRD) patterns 
were collected on a X’Pert PRO-MPD (PANalytical, Almelo, The Netherlands, Cu Kα 
radiation, X’Celerator linear detector system, step size of 0.033°, ambient conditions).  
The fibrous scaffolds were investigated by means of scanning electron microscopy (SEM, 
FEI, Eindhoven, The Netherlands, Nova NanoSEM 450, voltage 3-5 kV) after sputtering them 
with a 3 nm platinum layer (Leica Microsystems, Wetzlar, Germany, EM SCD005). The 
BG45S5 nanoparticle content was verified gravimetrically using a thermoanalyser (Linseis, 
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Selb, Germany, PT1600). The degradation of PLGA was determined after electrospinning 
(with or without BG45S5 nanoparticles). Additionally, the reduction of the molecular weight 
of PLGA in the course of anaerobic incubation of the electrospun scaffolds in medium (see 
section 2.4) at 37°C and 5% CO2 for 2 weeks with regular medium change was followed. 
Electrospun scaffolds (50 ± 2 mg) were dissolved in THF and centrifuged (21’500 × g, 10 
min, Hitachi Koki, Tokyo, Japan, himac CT15E). The supernatant was taken and THF was 
evaporated at 60°C. The remaining PLGA was analysed with gel permeation chromatography 
(GPC, flow rate 1 mL min-1, Viscotek TDA, Malvern, UK) using chloroform as eluting 
solvent. Pieces of the incubated scaffolds were taken to track morphological changes of the 
fibres by SEM after 3 washing steps in Millipore water. 
 
2.4 pH evolution 
50 ± 2 mg of electrospun pure PLGA and electrospun BG45S5/PLGA were immersed in 500 
µL medium (400 µL NaCl solution (Braun, Melsungen, Germany, 0.9%) and 100 µL broth 
(standard nutrient broth I, Carl Roth, Karlsruhe, Germany, prepared according to 
manufacturer’s instructions)). The pH change was assessed immediately after immersion 
without incubation using a pH meter (Mettler Toledo, Greifensee, Switzerland, FiveEasy, 
FE20). Subsequently, the scaffolds were incubated at 37°C and 5% CO2 under anaerobic 
conditions and pH was measured after 0.25, 0.5, 1, 2, 4, 8 and 24 h (n = 3). 
 
2.5 Oral bacteria experiments 
2.5.1 Bacteria culture and viability 
Prior to antibacterial experiments the electrospun scaffolds were sterilised by UV radiation 
(50 W m-2) on both sides for 30 min. The antibacterial activity of the two types of electrospun 
scaffolds was investigated with bacteria from pooled saliva. The unstimulated saliva was 
collected from 14 volunteers over a period of 3 h (aged 26-50 years, with good oral health, 
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smokers and non-smokers). Samples were centrifuged (3 min, 1200 rpm, Eppendorf, 
Hamburg, Germany, Minispin) and supernatant was pooled afterwards by vortexing for 1 min. 
Broth with 15 vol% glycerol was added to the pooled saliva in equal ratio. The mixture was 
divided in 1 mL aliquots and stored at -20°C. 
The scaffolds (50 ± 2 mg) were incubated with 50 µL bacteria suspension, 50 µL broth and 
400 µL NaCl solution. The bacteria suspension was gained by thawing aliquots of pooled 
saliva, followed by centrifugation (1 min, 3000 rpm) and resuspension in broth for 1h at 37°C 
and 5% CO2. Afterwards, the incubation of bacteria with the scaffolds for 2 h or 24 h 
(separate tests) was carried out under anaerobic conditions at 37°C and 5% CO2. After 
incubation, colony-forming units (CFU) per mL were assessed from 100 µL bacterial 
suspension. The incubated suspension was vortexed, diluted in NaCl solution and cultured on 
Columbia blood agar plates (VWR, Radnor, USA). The threshold values determinable for 
log10 CFU per mL were 2.0 at the minimum and 8.6 at the maximum. Furthermore, pH of the 
suspension after incubation was assessed. As references to the tubes incubated with the 
electrospun scaffolds, the solutions summarised in Table 1 were additionally measured. 
Again, 50 µL bacteria suspension and 50 µL broth were incubated with 400 µL of the 
respective reference solution. In addition to CFU counted after 24 h for every reference, pure 
medium and BG45S5 nanoparticle dispersions were also tested after 2 h. Two test series were 
carried out with independently thawed aliquots. Per series each material and reference was 
tested in triplicate (overall n = 6).  
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Table 1. pH, concentration and preparation of the solutions serving as references for the 
bacteria culture experiments with PLGA and BG45S5/PLGA scaffolds.  
reference pHa concentration buffer 
adjusted 
with  
name 
NaCl solution 7.4 0.9% dnab medium 
HCl (Sigma-Aldrich, St Louis, USA, 
37%) in NaCl solution 
1.9 50 mmol L-1 dnab HCl 
lactic acid buffer solution in NaCl 
solution made with sodium L-lactate 
(Sigma-Aldrich, St Louis, USA, 
98%) 
3.5 50 mmol L-1 HCl in NaCl 
solution 
lactic acid 
phosphate buffered saline 
(Invitrogen, Carlsbad, USA) 
7.4 dnab dnab PBS 
NaHCO3 (Fluka Analytical, St 
Louis, Ph. Eur.) buffer solution in 
NaCl solution 
7.8 50 mmol L-1 HCl in NaCl 
solution 
NaHCO3 
NaOH (Merck, Darmstadt, 
Germany, Ph. Eur.) in NaCl solution 
9.7 c NaCl 
solution 
NaOH 
TAPSd (Sigma-Aldrich, St Louis, 
USA, 99%) buffer solution in NaCl 
solution 
9.9 50 mmol L-1 NaOH in 
NaCl 
solution 
TAPS 
BG45S5 particles 11.5 15 mg in 500 
µL medium 
dnab BG45S5 
particles 
a initial pH of the solution before addition of broth and bacteria suspension 
b does not apply 
c 9 mmol L-1 NaOH in NaCl solution adjusted to pH with NaCl solution 
d 3-[N-Tris-(hydroxymethyl)methylamino]-2-hydroxypropanesulphonic acid 
 
2.5.2 Bacteria and scaffold imaging  
Confocal laser scanning microscopy (CLSM, Leica Microsystems, Wetzlar, Germany, SP5) 
was used to determine the bacteria viability qualitatively and to determine their appearance in 
the fibrous mesh. After incubation, the sample was vortexed and the medium was 
subsequently aspirated from the scaffold. Then, the PLGA or BG45S5/PLGA scaffolds were 
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washed in NaCl solution, fixed with 4% paraformaldehyde in the dark at RT for 60 min and 
washed once more with NaCl solution. LIVE/DEAD BacLight staining was used according to 
the manufacturer’s instructions (Invitrogen, Carlsbad, USA). To that effect, stock solution A 
and B were mixed in equal ratios. After staining, the scaffolds were attached onto glass slides 
with the help of Mowiol (Sigma-Aldrich, St Louis, USA). Curing took 6 h in the dark. Images 
were taken with a 63 × (glycerol immersion, numerical aperture: 1.3) objective and an Argon, 
Helium, Neon laser with excitation/emission maxima of 488/500 nm and 561/635 nm using 
fluorescein isothiocyanate and TexasRed fluorescence filters. Each sample was examined by 
taking at least one stack with z step size < 1 µm. Image processing was performed with Imaris 
Software (Bitplane Scientific Software 7.5.1) after deconvolution using Huygens Remote 
Manager (Scientific Volume Imaging B.V. 2.1.2). 
 
For SEM, the scaffolds were washed with NaCl solution and fixed in 10 wt% glutaraldehyde 
solution (Sigma-Aldrich, St Louis, USA, 25%) for 30 min. Dehydration was achieved 
gradually (2 × 15 min in ethanol 50 vol%, 2 × 15 min in ethanol 70 vol%, 2 × 15 min in 
ethanol 80 vol%, 2 × 15 min in ethanol 90%, 3 × 20 min and 2 × 60 min in ethanol absolute, 
Scharlau Chemie, Sentmenat, Spain, Ph. Eur.).  
 
2.5.3 Bacteria identification 
Bacteria species were determined with the help of mass spectrometric methods by Mabritec 
AG (Riehen, Switzerland). Four different samples were analysed in terms of species presence: 
the inoculum and samples incubated for 24 h at 37°C and 5% CO2 under anaerobic conditions 
in pure medium or with PLGA or BG45S5/PLGA (n = 3). 
 
2.6 Statistical analysis 
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The results of the CFU counting were obtained by log10-transformation of the values. The so-
obtained values of the samples were normalised to the respective inoculum value (2 separate 
aliquots from the same pool) and are expressed as average ± standard deviation of the mean. 
Statistical significance was evaluated by one-way ANOVA with Bonferroni correction. 
Statistical significance was accepted at p < 0.05. 
 
3. Results and discussion 
3.1 Spherical, dispersible BG45S5 nanoparticles 
Brunauer-Emmet-Teller (BET) measurement of the BG45S5 nanoparticles gave a specific 
surface area of 40 ± 4 m2 g-1 corresponding to a primary particle diameter of 60 nm if the 
particles are assumed to be spherical. As shown in Figure S1, TEM supported the assumption 
of spherical particles and showed similar particles as those presented in previous publications 
[37, 38]. XRD pattern confirmed the BG45S5 nanoparticles to be XRD-amorphous (data not 
shown). 
 
3.2 Nanocomposite scaffolds 
Scaffolds made of pure PLGA or composed of BG45S5 nanoparticles and PLGA were 
prepared by electrospinning. Thermogravimetric analysis of the electrospun scaffolds 
containing BG45S5 nanoparticles confirmed that the nominal content of 30 wt% was 
achieved (29 ± 3 wt%, n = 16). SEM micrographs of as prepared electrospun scaffolds are 
shown in Figure 1. The average fibre diameter (n = 100) of the pure PLGA fibres was 4990 ± 
810 nm compared to 520 ± 160 nm for BG45S5/PLGA fibres. The diameter of pure PLGA 
fibres was in agreement with data published earlier [39, 41-43]. On the other hand, the smaller 
diameter of the BG45S5/PLGA fibres might have several causes. Most importantly, BG45S5-
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containing fibres were electrospun from a different solvent system. The morphological 
appearance of the fibres was similar to that obtained by Dinarvand et al. [28]. 
Figure 2a summarises the GPC results. As anticipated, the presence of bioactive glass caused 
slightly faster degradation during incubation with medium. The electrospinning process 
resulted in a material with weight average molecular weight that was in the same range as 
extruded PLGA and slightly below solvent casted PLGA [44].  
SEM micrographs of the immersed scaffolds proved that the morphology of the pure PLGA 
fibres did not change over incubation time (Figure S2 in the Supplementary data). However, it 
seemed as if the mesh was denser. In the case of BG45S5/PLGA, the fibrous morphology was 
lost (Figure S2 in the Supplementary Data). Crystallites demonstrating the mineralisation of 
the material were not as clearly visible as in in vitro studies with bioactive glasses (45S5 
composition) in SBF or PBS [36, 37, 45], as neither calcium nor phosphate ions were present 
in the here applied incubation medium. However, it is legitimate to hypothesise the presence 
of apatite on the fibres as confirmed by Gubler et al. with corresponding Raman peaks when 
using the same BG nanoparticles in the same immersion medium (NaCl) [46]. 
 
3.3 pH evolution 
The influence of the presence of BG45S5 in the PLGA fibres on the pH is depicted in Figure 
2b. Compared to results reported in literature [14, 17, 22, 25] using PLGA with different L/G 
ratio and processed with other methods, in our case the pH drop caused by PLGA was more 
pronounced. For one, part of the mentioned studies examined the pH evolution in buffered 
solutions. Secondly, as bacteria culture conditions with 5% CO2 and under anaerobic 
atmosphere favour a pH decrease, the acidity increased within 24 h in our case. BG45S5 
buffers the pH decrease induced by the presence of PLGA. As a matter of fact, in literature it 
is often suggested to revert to orthopaedic implants made of PLGA and BG45S5 in order to 
avoid immune reactions like inflammations [1, 14, 17, 25]. 
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From the opposite point of view, the antimicrobial effect of BG45S5 (nano-)particles is based 
on the pH increase that they induce [10, 46, 47], in addition to an ion release effect [46]. 15 
mg of BG45S5 nanoparticles in 500 µL medium caused the pH to rise to 11.5 (see Table 1) 
and after 24 h incubation at 37°C and 5% CO2 the solution still presented a pH of 9.3 (see 
Table 2, below). If compared to previous studies using micron-sized BG and a more buffered 
medium, these values were slightly higher [48]. As expected, 50 mg of BG45S5/PLGA 
electrospun fibres provoked, in the same amount of medium a more moderate elevation of the 
pH (10.1, Figure 2b). After incubation for 24 h the pH dropped to 7.8 (Figure 2b). 
 
3.4 Oral bacteria experiments 
3.4.1 Bacteria culture and viability 
In the following, the antimicrobial effect of the two materials was evaluated in order to 
determine which of them offered the more promising features to be used in dental 
applications. Hence a pool of mixed bacteria was investigated. Figure 3 illustrates the 
evolution of the bacteria viability. The reference in pure medium confirmed that bacteria had 
enough nutrients to grow (log10 CFU per mL of the inoculum: ~6.8, after 2 h: ~6.0 and after 
24 h: ~6.6). In comparison, BG45S5 nanoparticles completely killed all bacteria within 24 h. 
This result is in agreement with previous studies. Similar to BG45S5 nanoparticles, the 
electrospun BG45S5/PLGA fibres initially showed an antimicrobial effect after 2 h. However, 
it seems that the composite material neither raised the pH enough nor did it keep the pH 
sufficiently long at elevated levels to kill all the bacteria. After 24 h the bacteria had 
recovered completely. In addition to this apparently too short pH rise, the increased viability 
after 24 h compared to culture in pure medium implies that the BG45S5 (phosphate-
containing) acts as an additional nutrient source. On the other hand, PLGA electrospun fibres 
do not present a statistically significant influence on bacterial viability if compared to pure 
medium at first (2 h). Yet, after 24 h the CFU dropped significantly. To our best knowledge 
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the antimicrobial properties of PLGA have been studied only as a reference to scaffolds 
containing drugs [49, 50]. Unfortunately, in both cases, a different L/G ratio and combinations 
with other polymers do not allow a direct comparison to be drawn to our results.  
Table 2 gives an overview on the evolution of the pH and puts it in context with the CFU 
results. High CFU counts after 24 h were observed for the solutions presenting a pH between 
4 and 8 after incubation which is consistent with literature [51]. The disinfectant effect of HCl 
and the lactic acid buffered solution goes along with the results of Zhu et al. on E. coli and H. 
pylori [26]. PLGA brought the pH in the same range during incubation, which explains the 
CFU decline. The decrease in pH resulted in a stress-induced killing of bacteria. Only aciduric 
strains could survive, proliferate selectively and become dominant (see section 3.4.3).  
Allan et al. [10] stated the antibacterial effect of bioactive glass as a phenomenon related to 
the alkaline nature of its surface reactions. However, in this study the fibrous material 
somehow encapsulated the particles and, thus, released its allegedly antibacterial effect more 
slowly than mere BG particles. Compared to incubation with pure PLGA, bacterial incubation 
with BG45S5/PLGA fibers gave higher bacteria counts and higher diversity of bacterial 
species (see section 3.4.3). Hence, combination of BG45S5 and PLGA prevented the pH to 
increase enough to reach pH levels with an ultimate antibacterial effect after 24 h. 
TAPS buffer raised the pH to a similar level as BG45S5/PLGA fibres after 24 h. As a matter 
of fact, CFU were even uncountable after incubation in TAPS buffer. This confirmed the 
insufficiently high pH increase with creation of an enhanced bacteria friendly pH-
environment. 
Consequently, biomaterial properties can be modified and designed to embrace specific 
applications by adjusting the BG45S5 content in e.g. poly(α-hydroxyesters). Concerns 
regarding negative influences of the pH shift may rise [52]. Especially, a persistent pH 
decrease would make further investigations necessary in order to exclude severe long-term 
effects on the periodontal tissue. However, it can be assumed that the use of PLGA is 
unproblematic as it is already used in commercially available products for periodontal 
regeneration [53].Table 2. pH after 24 h of incubation at 37°C and 5% CO2 under anaerobic 
conditions with or without bacteria. Bacteria viability is expressed by means of CFU 
normalised to the CFU of the inoculum. In the case of bacteria culture in NaHCO3 and TAPS 
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buffer, the dilutions were not sufficiently high to obtain countable amount of CFU on the agar 
plates (log10 CFU per mL > 8.6) Same letters behind the value indicate no statistically 
significant difference.  
 pH after 24 h 
without bacteria 
(n = 2) 
pH after 24 h with 
bacteria (n = 6) 
CFU after 24 h 
normalised to initial 
CFU (n = 6) 
PLGA 3.8 ± 0.2 3.6 ± 0.1 0.57 ± 0.17 
BG45S5/PLGA 7.9 ± 0.3 8.0 ± 0.1 1.09 ± 0.08, a 
NaCl 5.8 ± 0.1 4.4 ± 0.2 0.97 ± 0.19, a 
HCl 2.6 ± 0.1 2.6 ± 0.1 no CFU, b 
lactic acid 3.7 ± 0.1 3.7 ± 0.1 no CFU, b 
PBS 6.4 ± 0.2 5.3 ± 0.4 1.01 ± 0.06, a,c 
NaHCO3 7.5 ± 0.3 7.6 ± 0.1 not determinable 
NaOH 6.0 ± 0.1 4.6 ± 0.1 0.87 ± 0.05, c 
TAPS 7.4 ± 0.1 7.4 ± 0.1 not determinable 
BG45S5 particles 9.3 ± 0.1 9.5 ± 0.5 no CFU, b 
 
3.4.2 Bacteria and scaffold imaging 
On CLSM images (Figure 4), dead bacteria appeared red while living bacteria were green. 
Indeed, the differentiation of living and dead bacteria was possible. For PLGA, most bacteria 
were found at the scaffolds’ border whereas BG45S5/PLGA scaffolds presented a distribution 
of living and dead bacteria throughout the fibrous mesh. The structure of the PLGA scaffolds 
looked loose and more porous in comparison with the entangled morphology of the 
BG45S5/PLGA scaffolds. This observation was confirmed by SEM.  
Pure PLGA electrospun fibres presented the same morphology after 24 h bacteria culture as 
fibres incubated for 2 weeks without bacteria (Figure S2). Bacteria were found neither after 2 
h nor after 24 h. After all, as CLSM had already shown, the bacteria were less embedded in 
the PLGA scaffolds compared to the BG45S5/PLGA mesh. Moreover, vortexing might have 
caused removal of the bacteria from the scaffolds to a certain degree. On the contrary, 
BG45S5/PLGA allowed observation of bacteria (Figure 5). After 24 h bacteria were spotted 
in the fibrous web. Similarly to CLSM images, bacteria appeared accumulated in certain parts 
of the scaffolds and were not homogenously distributed over the scaffold.  
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3.4.3 Bacteria identification 
Bacteria identification with the help of mass spectrometry was carried out for the inoculum 
and samples where bacteria were incubated for 24 h in pure medium or with PLGA or 
BG45S5/PLGA. The results are summarised in Table 3. Various Streptococcus species were 
present in the inoculum. These are typically found in the oral cavity [54]. It is noteworthy that 
after incubation with BG45S5/PLGA neither Streptococcus parasanguinis nor Streptococcus 
mitis/oralis/pseudopneumoniae were identified. As for PLGA, if CFU formed, only 
Lactobacillus paracasei was determined (2 samples did not present any CFU). This strain is 
most probably also present in the inoculum but is overgrown by the Streptococci. It is not 
surprising that Lactobacillus paracasei is the only species found after incubation with PLGA, 
as the Lactobacillus genus is known to grow best in slightly acidic media with initial pH of 
6.4 – 4.5. Its growth is optimal under anaerobic conditions possibly stimulated with increased 
CO2 concentration (5%) and ceases when pH 4.0 – 3.6 is reached [55]. 
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Table 3. Qualitative identification of the bacteria. Besides inoculum, samples incubated for 24 
h at 37°C and 5% CO2 under anaerobic conditions either in pure medium or with PLGA or 
with BG45S5/PLGA were tested (n = 3). If the bacteria species was identified by mass 
spectrometry a plus (+) is noted. A minus (–) is noted when the species was not detected. 
bacteria species inoculum medium PLGA BG45S5/PLGA 
Streptococcus parasanguinis + + - - 
Streptococcus mitis/oralis/pseudopneumoniae + + - - 
Streptococcus sp. - + - + 
Streptococcus gordonii + - - + 
Streptococcus sanguinis + - - + 
Streptococcus sp. / cristatus - - - + 
Streptococcus salivarius + + - + 
Lactobacillus paracasei - - + - 
no CFU - - + - 
 
4. Conclusion 
Antimicrobial properties of electrospun PLGA and PLGA with BG45S5 nanoparticles were 
investigated. The evolution of CFU of human oral bacteria was brought into association with 
the pH shift of the medium induced by the scaffolds. It can be concluded that even if 
advantageous in orthopaedics the buffering effect of BG45S5 in polymeric composites 
prevents disinfection in dental applications. This shows that the optimal biomaterial design 
has to be adapted on the targeted function. 
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Figure Captions 
 
Figure 1 Structure and morphology of as prepared scaffolds. Compared to the smooth PLGA 
fibres (a), the BG45S5 fibres presented nanoparticles at their surface (b). 
 
Figure 2 Evolution of the molecular weight of PLGA in the scaffolds (a). Starting from as 
prepared scaffolds to scaffolds incubated at 37°C and 5% CO2 under anaerobic conditions for 
2 weeks, degradation was determined by GPC. Both scaffolds PLGA (Δ) and BG45S5/PLGA 
(●) are shown. Evolution of the pH (b). The measurement started with pure medium (×, 0 h) 
and the immediate pH change (0.05 h) induced by PLGA (Δ) or BG45S5/PLGA (●) before 
incubation is shown. During incubation at 37°C and 5% CO2 under anaerobic conditions 
starting at 1 h the pH decreased. 
 
Figure 3 Evolution of CFU found in samples incubated for 2 h (left) or 24 h (right) at 37°C 
and 5% CO2 under anaerobic conditions in pure medium, with PLGA, with BG45S5/PLGA or 
with BG45S5 particles (n = 6). A full disinfection was obtained with BG45S5 nanoparticles. 
It is noteworthy that the reduction of CFU after 24 h for bacteria incubated with PLGA is 
statistically significant as indicated (p < 0.05).  
 
Figure 4 Appearance of the bacteria on the scaffolds by means of CLSM after cultivation for 
24 h on PLGA (a, c, e) or on BG45S5/PLGA (b, d, f). Micrographs for channel 488/500 (a, b) 
and channel 561/635 (c, d) are shown separately and combined in an overlay (e, f). Living 
bacteria fluoresced green while dead bacteria emitted red fluorescence. On PLGA, the 
bacteria were found mostly at the scaffold’s border as opposed to the broader distribution of 
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bacteria in the BG45S5/PLGA mesh. The PLGA fibres appeared loose in comparison with the 
entangled BG45S5/PLGA fibres.  
 
Figure 5 Structure and morphology of the scaffolds by means of SEM after BG45S5/PLGA 
were cultured for 2 h (a, b) or for 24 h (c, d) at 37°C and 5% CO2 under anaerobic conditions 
with bacteria. SEM also showed bacteria on the scaffolds incubated for 24 h as indicated in 
(c) with arrows and magnified in (d).  
 
 





Supplementary data 
 
 
 
Figure S1 TEM of the flame spray-derived BG45S5 nanoparticles confirmed the spherical 
shape and the nano-size of the particles. 
  
 
 
Figure S2 Structure and morphology of scaffolds incubated at 37°C and 5% CO2 under 
anaerobic conditions for 2 weeks in pure medium. Pure PLGA fibres kept their morphology 
(a), whereas for BG45S5/PLGA scaffolds the fibrous mesh was mostly lost (b). 
 
